Navigation Links
Resistant Influenza strains creates panic in US

Rick A. Bright, an immunologist at the U.S. Centers for Disease Control and Prevention said that all samples of seasonal influenza virus this year have developed // resistance to adamantanes, the class of drugs which is used for the treatment for flu infection.

Drugs belonging to this class like amantadine and rimantadine are ineffectual for now and for the foreseeable future and shouldn't be used.

The findings were reported in the Journal of the American Medical Association. Amantadine and rimantadine were the pivotal drugs used against influenza A.

Statistics show that about 10-15% of the U.S. population suffers due to flu every year, and about 31,000 people die of it. Vaccination is considered the best strategy to prevent infection.

It was found that 91% of the 120 influenza a virus samples that were tested were resistant to these two drugs.

Presently a total of 209 influenza isolates (including the original 120) from 26 states across the United States were collected and analyzed. Overall resistance was found to be 92 %.

The researchers were very surprised at the speed with which the influenza strains develop the resistance. They feel that this is due to the widespread, over-the-counter and unregulated use of the drugs in other countries.

Tamiflu (oseltamivir) and Relenza (zanamivir) both the antiviral drugs belong to the neuraminidase inhibitor class of antivirals. The virus has not developed resistance against this class of drugs and hence can be used. But researchers fear that people will be using them more and might begin using them inappropriately and, with increased and inappropriate use, this will also become ineffective against the virus.

The researchers feel that there is an increased necessity for more energy and resources to be devoted to develop new antiviral drugs. In the end they conclude by saying that vaccines are the true way to protect oneself against influenz a.


'"/>




Related medicine news :

1. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
2. Hope for Chemo-Resistant Leukemia Patients
3. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
4. HIV Virus Emerging Drug Resistant In UK, Prompting Fear Of A Second Epidemic
5. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
6. Treatment Resistant Tumors Can Be Targeted Better Using Botox
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. ‘Drug Resistant TB’ Rattles the Union Ministy
9. Malaria Resistant Mosquitoes Could Help In Combating Malaria
10. Tumor Resistant Mice Point To Novel Cancer Treatments
11. Mad-Cow Resistant Calf Cloned in China
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... ... February 27, 2017 , ... Texas based ... In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds 150,000. ... company had 800 customers and 2,250 RCEs at the time of acquisition. In ...
(Date:2/27/2017)... , ... February 27, 2017 , ... New Jersey ranks ... among all types and genders. And the need for advanced services is growing. ... its top-rated cancer care program, in collaboration with their non-profit partners in their fight ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... NuevaCare, a ... as diverse as Millbrae, Belmont, and Palo Alto, is proud to announce an important ... Bay Area consumers look for home care close to home, and by having city-specific ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ODH, Inc.™ ... Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director ... to use behavioral health analytics to improve Medicaid population health management. , ODH will ...
(Date:2/24/2017)... Prior Lake MN (PRWEB) , ... February 24, ... ... the launch of its newly designed TaskMate Go. Core benefits and advantages built ... grain finish and a stylish, functional look and feel. Ability to gain the ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 2017   Royal Philips (NYSE: ... in health technology, today announced 510(k) clearance from ... market its ElastQ Imaging capability, further expanding the ... ElastQ Imaging enables simultaneous imaging of tissue and ... the diagnosis of various liver conditions. With ElastQ ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
(Date:2/27/2017)... , Feb. 27, 2017  CTI BioPharma Corp. (CTI BioPharma) ... Adam Craig , M.D., Ph.D., as President and Chief Executive ... March 20, 2017. Dr. Craig succeeds Richard Love , ... the company,s Board of Directors.  Dr. Craig has over 20 ... both the US and Europe . ...
Breaking Medicine Technology: